Office of Research & Development |
|
Project Number: | I01BX005651-01A2 |
| Title: | Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19 |
| Principal Investigator: | Edward D. Chan |
| Location: | Denver, CO |
| Congressional District Code: | 1 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | July 2023 - June 2027 |
| FY 2025 Funding Amount: | $156,800 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |